Cambridge Heart Inc. (OTC:CAMH) plans to bring its HearTwave II Microvolt T-Wave Alternans (MTWA) test for sudden cardiac arrest to Singapore through an exclusive distribution deal with EO Medical Pte Ltd.
The deal hinges on the MTWA device winning regulatory approval in Singapore, which the Tewksbury, Mass.-based company expects within the next 6 to 9 months.